Teladoc (TDOC) Stock Dips While Market Gains: Key Facts
The latest trading day saw Teladoc (TDOC) settling at $8.60, representing a -0.92% change from its previous close.
Teladoc Health Needs A Turnaround Plan
Teladoc Health, Inc. shows signs of bottoming out after withdrawing guidance due to customer acquisition issues, particularly in the BetterHelp division. The new CEO must drive product innovation to capitalize on growth opportunities in weight loss management and chronic care management. The stock is trading at a deep valuation, around 5x EBITDA targets, providing a potential investment opportunity despite current challenges.
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
Teladoc (TDOC) reachead $8.41 at the closing of the latest trading day, reflecting a -0.71% change compared to its last close.
Why Teladoc Stock Popped by Nearly 12% on Tuesday
An analyst raised his price target on the telehealth leader. The 25% increase was considerable.
Teladoc rises on increased demand, should you buy this high risk play?
Teladoc health's services witness an increase in demand according to the latest web traffic figures, as per Jeffries analysts.
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) closed at $8.16 in the latest trading session, marking a +0.87% move from the prior day.
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) closed at $7.25 in the latest trading session, marking a +0.83% move from the prior day.
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
Here's Why Teladoc (TDOC) Gained But Lagged the Market Today
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.17, denoting a +0.99% change from the preceding trading day.
Teladoc Health's New CEO Emphasizes Potential for Improvement Amid Mixed Results
Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do.
Is There Any Hope for Teladoc Stock?
Teladoc's second-quarter financial results disappointed investors. The telemedicine company still has several things going its way.
